The success of LEQEMBI and the progress in vaccine development have reignited interest in Alzheimer’s research, with potential implications for how we understand, treat, and possibly prevent this devastating disease.
The biotech breakthroughs in 2023 have opened new doors in Alzheimer’s research, providing a foundation for future innovations. The success of LEQEMBI and the progress in vaccine development have reignited interest in Alzheimer’s research, with potential implications for how we understand, treat, and possibly prevent this devastating disease.